Cisa shingrix lead study
Ended Awarded Last action
- Contract number
- 75D30120F00017
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $457,100
Award facts
- Contract value 91% obligated
- $499,784.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621399 Offices of All Other Miscellaneous Health Practitioners
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$39,748 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $496,847 |
About this award
Duke University Office of Research Administration Division was awarded a $499,784 firm fixed price delivery order against its Clinical Immunization Safety Assessment (CISA) indefinite-delivery/indefinite-quantity (IDIQ) contract with the Centers for Disease Control and Prevention (CDC). The delivery order is for a CISA SHINGRIX lead study to be performed in Durham, North Carolina by November 2022. Duke University holds the CISA IDIQ contract with CDC, valued at up to $86 million through September 2028, to provide clinical research and immunization safety assessment services in support of CDC programs. No set-aside designation was specified for this delivery order award.
Quick answers
Who was awarded contract 75D30120F00017?
75D30120F00017 was awarded to Duke University by CDC Pittsburgh (Centers for Disease Control and Prevention) on October 1, 2020.
How much is contract 75D30120F00017 worth?
The government has obligated $457,100 on 75D30120F00017. Its current value, with exercised options, is $499,784.
Is contract 75D30120F00017 an order under another contract?
Yes. 75D30120F00017 is a delivery order under HHSD200201253663I, an indefinite delivery contract, on Clinical Immunization Safety Assessment (CISA).
Was contract 75D30120F00017 competed?
The extent of competition for 75D30120F00017 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award